Correlation and expression analysis of hypoxia‑inducible factor 1α, glucose transporter 1 and lactate dehydrogenase 5 in human gastric cancer

Hao,Lang‑Song; Liu,Qi; Tian,Chuan; Zhang,Dong‑Xing; Wang,Bo; Zhou,Dong‑Xu; Li,Zhao‑Peng; Yuan,Zhi‑Xiang

doi:10.3892/ol.2019.10457

Correlation and expression analysis of hypoxia‑inducible factor 1α, glucose transporter 1 and lactate dehydrogenase 5 in human gastric cancer

Authors:
- Lang‑Song Hao
- Qi Liu
- Chuan Tian
- Dong‑Xing Zhang
- Bo Wang
- Dong‑Xu Zhou
- Zhao‑Peng Li
- Zhi‑Xiang Yuan
View Affiliations

Affiliations: Department of General Surgery, Guizhou Provincial People's Hospital, Guiyang Medical University, Guiyang, Guizhou 550002, P.R. China, Graduate School of Surgery, Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China, Department of Pharmacy, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan 611130, P.R. China
Published online on: June 7, 2019 https://doi.org/10.3892/ol.2019.10457
Pages: 1431-1441

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The development and identification of novel potential targeting sites for intervention therapy are essential in the search for improved treatment methods for gastric cancer (GC). Previously, it has been reported that hypoxia inducible factor‑1α (HIF‑1α) is a potential target gene involved in the endogenous hypoxic response and bioenergetic metabolism of GC cells. In the present study, with the assumption of a close interplay among HIF‑1α, glucose transporter 1 (GLUT1) and lactate dehydrogenase‑5 (LDH‑5), 85 patients with GC were recruited and the protein and gene expression levels of HIF‑1α, GLUT1 and LDH‑5 in tumor tissues were evaluated in order to assess clinical correlations and co‑expression patterns, using Immunohistochemical staining and reverse transcription‑quantitative polymerase chain reaction. The results demonstrated that the protein and gene expression levels of HIF‑1α were significantly associated with the depth of invasion, nodal metastasis, clinical stage, differentiation and distant metastasis. Consistent with the protein expression results, the mRNA expression levels of the genes coding for GLUT1 and LDH‑5 were clearly associated with tumor size, depth of invasion, distant metastasis, clinical stage and differentiation. Correlation analysis of HIF‑1α with GLUT1 and LDH‑5 at the protein and mRNA expression levels in gastric carcinoma indicated that HIF‑1α expression was positively correlated with the expression of GLUT1 (P<0.01, r=0.765 for mRNA expression; P<0.01, r=0.697 for protein expression) and LDH‑5 (P<0.01, r=0.892 for mRNA expression; P<0.01, r=0.783 for protein expression) at the mRNA and protein levels. Therefore, it may be concluded that HIF‑1α, GLUT1 and LDH‑5 are potential target genes involved in the endogenous tumor response to hypoxia and the inhibition of tumor energy metabolism, highlighting a novel therapeutic target for GC.

View Figures

View References

1	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
2	Rugge M, Fassan M and Graham DY: Epidemiology of gastric cancer. Gastric Cancer: Principles and Practice. Strong VE: Springer International Publishing; Cham: pp. 23–34. 2015, View Article : Google Scholar
3	Xuan Y, Hur H, Ham IH, Yun J, Lee JY, Shim W, Kim YB, Lee G, Han SU and Cho YK: Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism. Exp Cell Res. 321:219–230. 2014. View Article : Google Scholar : PubMed/NCBI
4	Lordick F, Allum W, Carneiro F, Mitry E, Tabernero J, Tan P, Van Cutsem E, van de Velde C and Cervantes A: Unmet needs and challenges in gastric cancer: The way forward. Cancer Treat Rev. 40:692–700. 2014. View Article : Google Scholar : PubMed/NCBI
5	Muz B, de la Puente P, Azab F and Azab AK: The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl). 3:83–92. 2015. View Article : Google Scholar : PubMed/NCBI
6	Zeng W, Liu P, Pan W, Singh SR and Wei Y: Hypoxia and hypoxia inducible factors in tumor metabolism. Cancer Lett. 356:263–267. 2015. View Article : Google Scholar : PubMed/NCBI
7	Semenza GL: HIF-1: Upstream and downstream of cancer metabolism. Curr Opin Genet Dev. 20:51–56. 2010. View Article : Google Scholar : PubMed/NCBI
8	Esfandiary A, Taherian-Esfahani Z, Abedin-Do A, Mirfakhraie R, Shirzad M, Ghafouri-Fard S and Motevaseli E: Lactobacilli modulate hypoxia-inducible factor (HIF)-1 regulatory pathway in triple negative breast cancer cell line. Cell J. 18:237–244. 2016.PubMed/NCBI
9	Koyasu S, Kobayashi M, Goto Y, Hiraoka M and Harada H: Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge. Cancer Sci. 109:560–571. 2018. View Article : Google Scholar : PubMed/NCBI
10	Li M, Wang YX, Luo Y, Zhao J, Li Q, Zhang J and Jiang Y: Hypoxia inducible factor-1α-dependent epithelial to mesenchymal transition under hypoxic conditions in prostate cancer cells. Oncol Rep. 36:521–527. 2016. View Article : Google Scholar : PubMed/NCBI
11	Isobe T, Aoyagi K, Koufuji K, Shirouzu K, Kawahara A, Taira T and Kage M: Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer. Int J Clin Oncol. 18:293–304. 2013. View Article : Google Scholar : PubMed/NCBI
12	Qian J, Hao B, Gao Z, Dong YU, Pei J, Ma M and Han B: Downregulation of HIF-1α inhibits the proliferation and invasion of non-small cell lung cancer NCI-H157 cells. Oncol Lett. 11:1738–1744. 2016. View Article : Google Scholar : PubMed/NCBI
13	Liu L, Ning X, Sun L, Zhang H, Shi Y, Guo C, Han S, Liu J, Sun S, Han Z, et al: Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci. 99:121–128. 2008.PubMed/NCBI
14	Wang J, Ni Z, Duan Z, Wang G and Li F: Altered expression of hypoxia-inducible factor-1α (HIF-1α) and its regulatory genes in gastric cancer tissues. PLoS One. 9:e998352014. View Article : Google Scholar : PubMed/NCBI
15	Chen J, Li T, Liu Q, Jiao H, Yang W, Liu X and Huo Z: Clinical and prognostic significance of HIF-1α, PTEN, CD44v6, and survivin for gastric cancer: A meta-analysis. PLoS One. 9:e918422014. View Article : Google Scholar : PubMed/NCBI
16	Zhu CL, Huang Q, Liu CH, Lin XS and Xie F: Prognostic value of HIF-1α expression in patients with gastric cancer. Mol Biol Rep. 40:6055–6062. 2013. View Article : Google Scholar : PubMed/NCBI
17	Liu X, Wang X, Zhang J, Lam EK, Shin VY, Cheng AS, Yu J, Chan FK, Sung JJ and Jin HC: Warburg effect revisited: An epigenetic link between glycolysis and gastric carcinogenesis. Oncogene. 29:442–450. 2010. View Article : Google Scholar : PubMed/NCBI
18	Szablewski L: Expression of glucose transporters in cancers. Biochim Biophys Acta. 1835:164–169. 2013.PubMed/NCBI
19	Fan R, Hou WJ, Zhao YJ, Liu SL, Qiu XS, Wang EH and Wu GP: Overexpression of HPV16 E6/E7 mediated HIF-1α upregulation of GLUT1 expression in lung cancer cells. Tumor Biol. 37:4655–4663. 2016. View Article : Google Scholar
20	Masoud GN and Li W: HIF-1α pathway: Role, regulation and intervention for cancer therapy. Acta Pharm Sin B. 5:378–389. 2015. View Article : Google Scholar : PubMed/NCBI
21	Rajaganeshan R, Prasad R, Guillou PJ, Poston G, Scott N and Jayne DG: The role of hypoxia in recurrence following resection of Dukes' B colorectal cancer. Int J Colorectal Dis. 23:1049–1055. 2008. View Article : Google Scholar : PubMed/NCBI
22	Oh S, Kim H, Nam K and Shin I: Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells. BMB Rep. 50:132–137. 2017. View Article : Google Scholar : PubMed/NCBI
23	Kayser G, Kassem A, Sienel W, Schulte-Uentrop L, Mattern D, Aumann K, Stickeler E, Werner M, Passlick B and zur Hausen A: Lactate-dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1. Diagn Pathol. 5:222010. View Article : Google Scholar : PubMed/NCBI
24	Kim HS, Lee HE, Yang HK and Kim WH: High lactate dehydrogenase 5 expression correlates with high tumoral and stromal vascular endothelial growth factor expression in gastric cancer. Pathobiology. 81:78–85. 2014. View Article : Google Scholar : PubMed/NCBI
25	Kolev Y, Uetake H, Takagi Y and Sugihara K: Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis. Ann Surg Oncol. 15:2336–2344. 2008. View Article : Google Scholar : PubMed/NCBI
26	Brierley JD, Gospodarowicz MK and Wittekind C: TNM classification of malignant tumours. 8th. John Wiley & Sons, Published in affiliation with the Union for International Cancer Control (UICC); 2016
27	Guan G, Zhang Y, Lu Y, Liu L, Shi D, Wen Y, Yang L, Ma Q, Liu T, Zhu X, et al: The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells. Cancer Lett. 357:254–264. 2015. View Article : Google Scholar : PubMed/NCBI
28	Yasuda M, Miyazawa M, Fujita M, Kajiwara H, Iida T, Hirasawa T, Muramatsu T, Murakami M, Mikami M, Saitoh K, et al: Expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: Difference in hypoxic status depending on histological character. Oncol Rep. 19:111–116. 2008.PubMed/NCBI
29	Koukourakis MI, Giatromanolaki A and Sivridis E; Tumour; Angiogenesis Research Group, : Lactate dehydrogenase isoenzymes 1 and 5: Differential expression by neoplastic and stromal cells in non-small cell lung cancer and other epithelial malignant tumors. Tumour Biol. 24:199–202. 2003. View Article : Google Scholar : PubMed/NCBI
30	Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e452001. View Article : Google Scholar : PubMed/NCBI
31	Pfaffl MW, Horgan GW and Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30:e362002. View Article : Google Scholar : PubMed/NCBI
32	Kitajima Y and Miyazaki K: The critical impact of hif-1a on gastric cancer biology. Cancers (Basel). 5:15–26. 2013. View Article : Google Scholar : PubMed/NCBI
33	Semenza GL: Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 29:625–634. 2010. View Article : Google Scholar : PubMed/NCBI
34	Schmitz KJ, Müller CI, Reis H, Alakus H, Winde G, Baba HA, Wohlschlaeger J, Jasani B, Fandrey J and Schmid KW: Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma. Int J Colorectal Dis. 24:1287–1296. 2009. View Article : Google Scholar : PubMed/NCBI
35	Cleven AH, van Engeland M, Wouters BG and de Bruïne AP: Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas. Cell Oncol. 29:229–240. 2007.PubMed/NCBI
36	Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
37	Lee K, Zhang H, Qian DZ, Rey S, Liu JO and Semenza GL: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proc Natl Acad Sci USA. 106:17910–17915. 2009. View Article : Google Scholar : PubMed/NCBI
38	Jung JH, Im S, Jung ES and Kang CS: Clinicopathological implications of the expression of hypoxia-related proteins in gastric cancer. Int J Med Sci. 10:1217–1223. 2013. View Article : Google Scholar : PubMed/NCBI
39	Baumann MU, Zamudio S and Illsley NP: Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1. Am J Physiol Cell Physiol. 293:C477–C485. 2007. View Article : Google Scholar : PubMed/NCBI
40	Courtnay R, Ngo DC, Malik N, Ververis K, Tortorella SM and Karagiannis TC: Cancer metabolism and the Warburg effect: The role of HIF-1 and PI3K. Mol Biol Rep. 42:841–851. 2015. View Article : Google Scholar : PubMed/NCBI
41	Kawamura T, Kusakabe T, Sugino T, Watanabe K, Fukuda T, Nashimoto A, Honma K and Suzuki T: Expression of glucose transporter-1 in human gastric carcinoma: Association with tumor aggressiveness, metastasis, and patient survival. Cancer. 92:634–641. 2001. View Article : Google Scholar : PubMed/NCBI
42	Marín-Hernández A, Gallardo-Pérez J, Ralph SJ, Rodríguez-Enríquez S and Moreno-Sánchez R: HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem. 9:1084–1101. 2009. View Article : Google Scholar : PubMed/NCBI
43	Danner BC, Didilis VN, Wiemeyer S, Stojanovic T, Kitz J, Emmert A, Füzesi L and Schöndube FA: Long-term survival is linked to serum LDH and partly to tumour LDH-5 in NSCLC. Anticancer Res. 30:1347–1351. 2010.PubMed/NCBI
44	Augoff K, Hryniewicz-Jankowska A and Tabola R: Lactate dehydrogenase 5: An old friend and a new hope in the war on cancer. Cancer Lett. 358:1–7. 2015. View Article : Google Scholar : PubMed/NCBI
45	Sevinc A, Sari R and Fadillioglu E: The utility of lactate dehydrogenase isoenzyme pattern in the diagnostic evaluation of malignant and nonmalignant ascites. J Natl Med Assoc. 97:79–84. 2005.PubMed/NCBI
46	Li XB, Gu JD and Zhou QH: Review of aerobic glycolysis and its key enzymes-new targets for lung cancer therapy. Thorac Cancer. 6:17–24. 2015. View Article : Google Scholar : PubMed/NCBI
47	Gillies RJ and Gatenby RA: Adaptive landscapes and emergent phenotypes: Why do cancers have high glycolysis? J Bioenerg Biomembr. 39:251–257. 2007. View Article : Google Scholar : PubMed/NCBI